# A Study of NovoTTF-200T(P) in Combination With Gemcitabine and Nab-Paclitaxel for Resectable Pancreatic Adenocarcinoma

Source: https://onco.cc/trials/nct05624918/  
OnCo record `nct05624918` (Trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)"; commercial use needs a licence.

## TL;DR

A phase 2 trial of nab-paclitaxel, gemcitabine and optune / Optune Pax (TTFields) in pancreatic cancer, run by Ashish Manne, now recruiting.

## Summary

A Study of NovoTTF-200T(P) in Combination With Gemcitabine and Nab-Paclitaxel for Resectable Pancreatic Adenocarcinoma is a phase 2, interventional study registered as NCT05624918 by Ashish Manne, with a registry enrolment figure of 38 participants, started 2024-07-01 and due to reach its primary completion in 2027-08-29. Interventions recorded: Nab paclitaxel; Gemcitabine; NovoTTF-200T(P). Conditions listed: Pancreatic Adenocarcinoma; Resectable Pancreatic Cancer. Primary outcome: 2 Year Overall Survival (OS); Rate of Resection. Pancreatic eligibility wording from the registry: "* Histological or cytological evidence of pancreatic adenocarcinoma". Sites: United States. No results are recorded here; the registry entry is the source.

## Fields

- Kind: Trial
- Status: recruiting
- Last checked: 2026-09-24
- Tags: ctgov-ingest; pancreatic-deep-dive
- Registry id: NCT05624918
- Phase: 2
- Setting: A Phase II Study of Peri-Operative NovoTTF-200T(P) in Combination With Gemcitabine and Nab-Paclitaxel for Resectable Pancreatic Adenocarcinoma
- Sponsor: Ashish Manne
- Enrolled: 38

## Sources

- ClinicalTrials.gov NCT05624918: https://clinicaltrials.gov/study/NCT05624918

## Connected records

- cancers: [Resectable pancreatic ductal adenocarcinoma](https://onco.cc/cancers/resectable-pdac/)
- technologies: [Cytotoxic chemotherapy](https://onco.cc/technologies/cytotoxic-chemotherapy/), [Tumour treating fields (TTFields)](https://onco.cc/technologies/ttfields/)
- drugs: [Gemcitabine](https://onco.cc/drugs/gemcitabine/), [Nab-paclitaxel](https://onco.cc/drugs/nab-paclitaxel/), [Optune / Optune Pax (TTFields)](https://onco.cc/drugs/optune/)
- terms: [Pancreatic cancer trials open today (registry snapshot and UK sites)](https://onco.cc/terms/pancreatic-trials-open-today/)

---
JSON: https://onco.cc/api/v1/entities/nct05624918.json